Zobrazeno 1 - 10
of 177
pro vyhledávání: '"T Mätzsch"'
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 9(2)
We have implanted a new port system (Percuseal) in altogether 13 patients with haemophilia A, B, von Willebrand disease and alpha1-antitrypsin deficiency in order to facilitate venous access. The Percuseal system differs from subcutaneous ports, such
Autor:
D, Bergqvist, P A, Flordal, B, Friberg, J, Frisell, M, Hedberg, K G, Ljungström, T, Mätzsch, S, Törngren
Publikováno v:
VASA. Zeitschrift fur Gefasskrankheiten. 25(2)
In this prospective randomized double-blind study the thromboprophylactic effect of postoperative low molecular weight heparin (tinzaparin) was compared with placebo in 80 patients undergoing emergency abdominal surgery. The fibrinogen uptake test wa
Publikováno v:
Thrombosis and haemostasis. 72(5)
The effect on haemostatic variables by dextran 70, enoxaparin and their combinations, given in doses of 500 ml i.v. and 40 mg s.c. respectively, was studied in a randomised cross-over fashion in twelve healthy male volunteers. Antifactor-IIa activity
Autor:
D. Bergqvist, T. Mätzsch
Publikováno v:
Vascular Surgery ISBN: 9780412586309
Reconstructive surgery for femoropopliteal occlusive disease, most commonly caused by arteriosclerosis, is the most commonly performed procedure in peripheral vascular surgery. A great step forward was taken by Kunlin1, who used autologous vein as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5a8927f3743b870153d1c78da6c34ac
https://doi.org/10.1007/978-1-4899-6854-8_28
https://doi.org/10.1007/978-1-4899-6854-8_28
Autor:
D, Bergqvist, T, Mätzsch
Publikováno v:
Der Orthopade. 22(2)
Awareness of cost-effectiveness aspects has become increasingly important within the health care sector in times of constrained resources. Health economics deal with methods of making choices under conditions of uncertainty and provide models for dec
Publikováno v:
Seminars in thrombosis and hemostasis. 19
Publikováno v:
Advances in experimental medicine and biology. 313
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 1(6)
Heparin is widely used as an antithrombotic agent, but one reported complication is thrombocytopenia associated with platelet aggregation. The mechanism is not fully clear but heparin interference in the prostaglandin production has been proposed. To
Autor:
D, Bergqvist, U S, Burmark, J, Frisell, O, Guilbaud, T, Hallböök, A, Horn, A, Lindhagen, H, Ljungner, K G, Ljungström, T, Mätzsch
Publikováno v:
Seminars in thrombosis and hemostasis.
A prospective randomized double-blind trial was performed comparing conventional low-dose heparin with a LMWH fragment (Kabi 2165, Fragmin) for thromboprophylaxis in elective general abdominal surgical patients. The first dose of the fragment was giv
Publikováno v:
Acta chirurgica Scandinavica. 156(6-7)
The effect of low molecular weight (LMW) heparin given once daily as prophylaxis against venous thrombosis was compared with that of dextran 70 in an open randomised trial of 100 patients undergoing elective total hip replacement. Four patients were